ICD-11 Delayed Another Two Years by World Health Organization

WHO ( aka “World Health Organization”) is delaying the presentation of  ICD-11 to the World Health Authority  from 2015 to 2017.  This should put to rest any question that the U.S. will move to ICD-10.

This means that ICD-11 wouldn’t be ready for at least another 10 years in the U.S.   Let’s look at the revised dates given the updated timeline from WHO.   The non-U.S. version of ICD-11 from WHO is expected in May 2015 (now 2017).  The U.S. would likely need  two years for development of the U.S. version, given what happened with the development of ICD-10 CM and ICD-10 PCS.

So, the earliest it would be available for study would be 2017 (now 2019), and the U.S. would need another 4 years to implement ICD-11 – so that brings us out to 2021 (now 2023), which is too far in the future.

Related Posts

Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. He leads a team that provides Cybersecurity best practices for healthcare clients, ICD-10 Consulting, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, Insurance Fraud, payor-provider disputes, and consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been quoted in the Wall Street Journal, New York Times, and National Public Radio.

Leave a Reply